Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The prevalence of hereditary angioedema in a Chinese cohort with decreased complement 4 levels. | World Allergy Organ J | 2022 | 34992711 | PubTator, text mining | PubMed |
| An anesthetic experience of hereditary angioedema type I patient undertook total laparoscopic hysterectomy - A case report. | Anesth Pain Med (Seoul) | 2022 | 34991189 | PubTator, text mining | PubMed |
| Novel function of THEMIS2 in the enhancement of cancer stemness and chemoresistance by releasing PTP1B from MET. | Oncogene | 2022 | 34974522 | PubTator, text mining | PubMed |
| Factor VII activating protease (FSAP) is not essential in the pathophysiology of angioedema in patients with C1 inhibitor deficiency. | Mol Immunol | 2022 | 34973499 | PubTator, text mining | PubMed |
| Hereditary angioedema caused by a novel intronic variant of SERPING1. | Pediatr Allergy Immunol | 2022 | 34971012 | PubTator, text mining | PubMed |
| Resistin forms a network with inflammatory cytokines and is associated with prognosis in major burns. | Burns | 2022 | 34961651 | PubTator, text mining | PubMed |
| COVID-19 triggers attacks in HAE patients without worsening disease outcome. | J Allergy Clin Immunol Pract | 2022 | 34954120 | PubTator, text mining | PubMed |
| A glomerular transcriptomic landscape of apolipoprotein L1 in Black patients with focal segmental glomerulosclerosis. | Kidney Int | 2022 | 34929253 | PubTator, text mining | PubMed |
| Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19. | Thromb Res | 2022 | 34922160 | PubTator, text mining | PubMed |
| TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C. | J Exp Med | 2022 | 34914824 | PubTator, text mining | PubMed |
| Association of Complement and MAPK Activation With SARS-CoV-2-Associated Myocardial Inflammation. | JAMA Cardiol | 2022 | 34910083 | PubTator, text mining | PubMed |
| Complement Blockade in Recipients Prevents Delayed Graft Function and Delays Antibody-mediated Rejection in a Nonhuman Primate Model of Kidney Transplantation. | Transplantation | 2022 | 34905763 | PubTator, text mining | PubMed |
| Proteolytic activation of the epithelial sodium channel (ENaC) by factor VII activating protease (FSAP) and its relevance for sodium retention in nephrotic mice. | Pflugers Arch | 2022 | 34870751 | PubTator, text mining | PubMed |
| Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19. | Blood Adv | 2022 | 34861681 | PubTator, text mining | PubMed |
| A unique circulating miRNA profile highlights thrombo-inflammation in Behçet's syndrome. | Ann Rheum Dis | 2022 | 34844932 | PubTator, text mining | PubMed |
| Angioedema Due to Acquired Deficiency of C1-Inhibitor: A Cohort Study in Spain and a Comparison With Other Series. | J Allergy Clin Immunol Pract | 2022 | 34844023 | PubTator, text mining | PubMed |
| Specific Targeting of Plasma Kallikrein for Treatment of Hereditary Angioedema: A Revolutionary Decade. | J Allergy Clin Immunol Pract | 2022 | 34838707 | PubTator, text mining | PubMed |
| Bioinformatics analysis and experimental validation of differentially expressed genes in mouse articular chondrocytes treated with IL-1β using microarray data. | Exp Ther Med | 2022 | 34815758 | PubTator, text mining | PubMed |
| The role of complement in the clinical course of hepatocellular carcinoma. | Immun Inflamm Dis | 2022 | 34813686 | PubTator, text mining | PubMed |
| Pharmacokinetic/pharmacodynamic modeling for dose selection for the first-in-human trial of the activated Factor XII inhibitor garadacimab (CSL312). | Clin Transl Sci | 2022 | 34811931 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=58